is semaglutide on the shortage list Novo's Wegovy and Ozempic removed from US FDA list, compounders notice GLP-1 Drugs: FDA Removes Semaglutide

Short-term low dose semaglutide treatment also resulted in normalization of fasting blood glucose in 80% of PCOS women with impaired fasting glucose (33)

Technical details are summarized in the FDA prescribing information and independent overviews such as StatPearls (both describe the ~1-week half-life and slow elimination)

Neither compound, in any formulation, can be legally dispensed as a pharmacy medicine as of this writing

Blocking the GLP-1 receptor or GLP-1 receptor antagonism triggered anti-tumor immune activity in mice with colorectal cancer, researchers found

New vendors are treated with suspicion until someone independently verifies their product